Company Overview

Healthy Extracts Inc. (OTCQB: HYEX) is a U.S.-based health and wellness company focused on the development, marketing, and distribution of nutraceutical and dietary supplement products. The company operates within the broader consumer health, functional nutrition, and wellness industries, with an emphasis on clinically studied plant-based ingredients designed to support cardiovascular, metabolic, and overall health. Public filings and company disclosures identify the company’s primary revenue drivers as branded supplement formulations sold through direct-to-consumer channels, retail distribution, and strategic partnerships.

The company’s portfolio has centered on products incorporating bergamot citrus extracts and related wellness compounds, particularly through formulations associated with cholesterol management, heart health, metabolic support, and immune function. Healthy Extracts has positioned itself around science-backed nutraceutical ingredients and licensing relationships tied to proprietary or clinically evaluated formulations. The company evolved from earlier corporate structures and transitioned toward the health supplement sector through acquisitions, licensing arrangements, and brand-focused commercialization initiatives intended to expand recurring consumer product sales.

Business Operations

Healthy Extracts generates revenue primarily through the sale of dietary supplements and nutraceutical products marketed under proprietary and licensed brands. Public disclosures indicate the company has focused heavily on commercialization of formulations utilizing bergamot extract technology, including products associated with the Bergamet ingredient platform. Operations include product formulation oversight, branding, digital marketing, distribution management, and retail channel expansion. Manufacturing activities appear to rely substantially on third-party production partners common within the supplement industry rather than vertically integrated pharmaceutical-scale manufacturing facilities.

The company’s operations are concentrated primarily in the United States, although management communications and investor materials have referenced efforts to pursue broader international commercialization opportunities through licensing and distribution relationships. Healthy Extracts has historically emphasized strategic alliances with ingredient developers, intellectual property holders, and wellness distributors to support market penetration. Available public information does not indicate the company maintains large-scale international subsidiaries or major industrial assets relative to larger multinational supplement companies. Data regarding certain partnership structures and long-term joint ventures remains inconclusive based on available public sources.

Strategic Position & Investments

Healthy Extracts’ strategic direction has focused on expanding its portfolio of clinically supported nutraceutical products while increasing brand visibility across e-commerce, practitioner, and retail distribution channels. The company has emphasized consumer demand trends tied to preventive healthcare, cholesterol management, metabolic wellness, and natural supplementation. Public communications and filings have also highlighted initiatives involving formulation innovation, customer acquisition efficiency, and broader commercialization of citrus-derived wellness compounds.

The company has pursued growth through licensing arrangements, intellectual property access, and targeted acquisitions tied to health supplement technologies and brands. Healthy Extracts has publicly referenced investment in expanding product awareness and strengthening distribution infrastructure rather than pursuing large-scale manufacturing or pharmaceutical development. Available public records do not indicate a highly diversified subsidiary structure, though the company has maintained relationships tied to branded nutraceutical ingredient commercialization. Information regarding the scale and long-term financial contribution of certain investments remains limited in publicly available filings.

Geographic Footprint

Healthy Extracts is headquartered in the United States and maintains its principal operational focus within the domestic nutritional supplement market. Its products are marketed primarily to U.S. consumers through online sales channels, wellness-focused retail distribution, and strategic commercial relationships. The company’s operational footprint appears relatively concentrated compared with larger global consumer health companies, though management has discussed opportunities for broader international product reach.

Public disclosures suggest the company has explored commercial relationships outside the United States, particularly in regions where nutraceutical demand and preventive health markets are growing. However, publicly available filings do not indicate extensive owned international infrastructure, major foreign manufacturing operations, or large overseas subsidiaries. Data regarding the scale of direct international revenue exposure is inconclusive based on available public sources.

Leadership & Governance

Healthy Extracts’ leadership has emphasized growth through science-backed nutraceutical commercialization, disciplined capital allocation, and expansion of consumer wellness brands. Company strategy, as described in public filings and investor communications, has centered on leveraging clinically studied ingredients and scalable supplement distribution rather than pursuing pharmaceutical regulatory pathways. Governance oversight is conducted through executive management and the company’s board structure in accordance with public company reporting obligations.

Key executives and leadership figures publicly associated with the company include:

• Duke Pitts – President and Chief Executive Officer
• Chris Bickel – Executive Vice President
• Robert Rico – Chief Financial Officer

Certain historical leadership roles and prior executive appointments may vary across reporting periods and public filings. Investors typically reference SEC filings, quarterly reports, annual disclosures, and OTC market disclosures for the most current governance information.